Notably, a study in rheumatoid arthritis shows that CCL21/CCR7 signaling increases the number of macrophages in synovial tissue and promotes joint inflammation, making CCL21 an attractive target for therapy. Here, CCR7 is linked to rheumatoid arthritis.